Abstract
Aim
To study the long-term visual result of photocoagulation of clinically significant macular edema (CSME) in diabetic patients in relation to baseline retinal vascular leakage assessed by vitreous fluorometry.
Methods
The study enrolled 36 eyes in 27 diabetic patients with CSME at baseline, all subsequently treated by photocoagulation. The diagnosis of CSME and treatment procedure followed the ETDRS criteria. The leakage through the retinal vessels was calculated as the blood–retinal barrier permeability. Five years after initial photocoagulation the patients were reexamined.
Results
The mean visual acuity decreased with 16 letters at follow-up, and in 15 eyes visual loss was substantial, with a decrease of 15 letters or more, corresponding to at least 3 lines. The baseline permeability was significantly higher in eyes with substantial visual loss than in eyes with more stable vision (14.2 nm/sec and 6.3 nm/sec respectively; p = 0.006), the corresponding odds ratio was 16.1 (95% CI: 1.8–146; p = 0.014). The level of retinopathy was significantly correlated to visual loss (Fisher’s exact test < 0.02).
Conclusion
Visual acuity decreased at follow-up, and a substantial visual loss of 3 or more lines in CSME was associated with higher retinal vascular leakage at baseline with an odds ratio of 16.1. For this relatively small sample, neither diabetes duration, age or HbA1c reached statistical significance, indicating that blood-retinal barrier permability is a strong predictor of the visual outcome. The results support the investigation of triamcinolone or VEGF inhibition in patients with severe leakage, and may help to identify patients in need for intravitreal injection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Early treatment diabetic retinopathy study research group (1991) Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report no.11. Ophthalmology 98:807–822
Early treatment diabetic retinopathy study research group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS report no.19. Arch Ophthalmol 113:1144–1155
Early treatment diabetic retinopathy study research group (1985) Photocoagulation for diabetic macular edema. ETDRS report no.1. Arch Ophthalmol 103:1796–1806
Early treatment diabetic retinopathy study research group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806
Strom C, Sander B, Larsen N, Larsen M, Lund-Andersen H (2002) Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci 43:241–245
Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS, Larsen M (2008) Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86:364–371
Chew E, Strauber S, Beck R, Aiello LP, Antoszyk A, Bressler N, Browning D, Danis R, Fan J, Flaxel C, Friedman S, Glassman A, Kollman C, Lazarus H, Diabetic Retinopathy Clinical Researh Network (2007) Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology 114:1190–1196
Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K (2008) Comparative theraphy evaluation of intravitreal bevacizumab and trimacinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 145:854–861
Vinten M, Larsen M, Lund-Andersen H, Sander B, la Cour M (2007) Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta Ophthalmol 85:21–26
Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P (2006) Intravitreal trimacinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 142:794–799
Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M (2008) The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol 86:284–291
Sander B, Larsen M, Moldow B, Lund-Andersen H (2001) Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42:433–438
Sander B, Thornit DN, Colmorn L, Strom C, Girach A, Hubbard LD, Lund-Andersen H, Larsen M (2007) Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Invest Ophthalmol Vis Sci 48:3983–3987
Moldow B, Sander B, Larsen M, Lund-Andersen H (1999) Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 40:1770–1775
Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N, Lund-Andersen H (2002) Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol 86:316–320
Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH (1994) Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol 72:553–559
Klein R, Klein B, Moss S, Davis M, DeMets D (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV Diabetic retinopathy. Ophthalmology 91:1464–1474
Cunha-Vaz J (1983) Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes. Diabetes 32:20–27
Castillo A, Benitez del Castillo JM, Diaz D, Sayagues O, Ruibal JL, Garcia-Sanchez J (1996) Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetes. A 4-year follow-up. Graefes Arch Clin Exp Ophthalmol 234:246–250
Sander B, Larsen M, Engler C, Strøm C, Moldow B, Lund-Andersen H (2002) Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier. Br J Ophthalmol 86:1139–1142
Klein R, Klein BE, Moss S, Cruickshanks KJ (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type diabetes. Ophthalmology 105:1801–1815
Acknowledgements
The study was supported by the Danish Diabetes Foundation and the VELUX Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sander, B., Hamann, P. & Larsen, M. A 5-year follow-up of photocoagulation in diabetic macular edema: the prognostic value of vascular leakage for visual loss. Graefes Arch Clin Exp Ophthalmol 246, 1535–1539 (2008). https://doi.org/10.1007/s00417-008-0892-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0892-6